Dual neurohormonal intervention in CV disease: angiotensin receptor and Neprilysin inhibition
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual neurohormonal intervention in CV disease: angiotensin receptor and Neprilysin inhibition
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 22, Issue 7, Pages 915-925
Publisher
Informa Healthcare
Online
2013-06-04
DOI
10.1517/13543784.2013.797962
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AT2 receptor agonists
- (2012) Ulrike M. Steckelings et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
- (2012) et al. EUROPEAN HEART JOURNAL
- Heart failure—does it matter whether LVEF is reduced?
- (2012) John GF Cleland et al. LANCET
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Review: Novel roles of nuclear angiotensin receptors and signaling mechanisms
- (2011) TanYa M. Gwathmey et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Combined neutral endopeptidase inhibitors
- (2011) Florim Cuculi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Factores pronósticos y supervivencia a largo plazo tras el diagnóstico inicial de insuficiencia cardiaca
- (2011) Raúl Quirós López et al. MEDICINA CLINICA
- Current challenges in the clinical management of hypertension
- (2011) Luis M. Ruilope Nature Reviews Cardiology
- Dual-Acting Angiotensin Receptor–Neprilysin Inhibition
- (2010) Julian Segura et al. CURRENT HYPERTENSION REPORTS
- Flow-mediated constriction: further insight into a new measure of vascular function
- (2010) T. Gori et al. EUROPEAN HEART JOURNAL
- Chronic vagal nerve stimulation for the treatment of human heart failure: progress in translating a vision into reality
- (2010) D. R. Van Wagoner EUROPEAN HEART JOURNAL
- Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
- (2010) Luis Miguel Ruilope et al. LANCET
- Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study
- (2009) T. Sawada et al. EUROPEAN HEART JOURNAL
- Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
- (2009) Jessie Gu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Resistant Hypertension: Diagnosis, Evaluation, and Treatment
- (2008) David A. Calhoun et al. HYPERTENSION
- Global burden of blood-pressure-related disease, 2001
- (2008) Carlene MM Lawes et al. LANCET
- Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema
- (2007) R M Fryer et al. BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started